Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
about
The role of L-type amino acid transporter 1 in human tumorsLigand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual ScreeningTargeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentMonoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycleThe mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneDietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet.Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas.The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancerNutrient transporters: the Achilles' heel of anabolism.ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.SLC Transporters: Structure, Function, and Drug Discovery.Positive Regulation of Decidualization by l-Type Amino Acid Transporter 1 (lat1) in Pregnant MiceProstate cancer and the unfolded protein response.Targeting the ATF4 pathway in cancer therapy.Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproatePET Tracers Beyond FDG in Prostate Cancer.Suppression of amino acid transporter LAT3 expression on proliferation of K562 cells.Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.Androgen receptor and nutrient signaling pathways coordinate increased amino acid transport in prostate cancer progression.Cross-talk between protein synthesis, energy metabolism and autophagy in cancer.Fibroblast-like synoviocyte migration is enhanced by IL-17-mediated overexpression of L-type amino acid transporter 1 (LAT1) via the mTOR/4E-BP1 pathway.miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth.Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.
P2860
Q26775785-E96696B9-258B-405F-A098-8DF3F300F524Q28550085-8C744086-649C-4D6E-9F04-D0459933510DQ28831339-99C3D523-8002-4993-8459-9D30C760F5D0Q33797210-10BD90AF-D14F-42E2-BF3F-84594F42D1C2Q34566607-71A372A7-4FB6-445B-BE71-3CB93B120229Q35028079-E8029774-44F9-4733-8578-8C364FFC3AA7Q35122964-0F4C5643-86C3-4E2B-8FAC-3AAD92745D92Q35478977-39FDE3C9-7EE0-46A6-892C-F803C56C5E97Q35757977-79E8283E-C0D7-4571-89E6-A8BB135208B8Q35857671-F34D1BC5-0904-4E72-8783-D3769EDE7208Q36130010-A695AD37-3B7C-4C7E-8CA5-1BF63A75DCF8Q36326330-5F8CDB5C-1511-4626-9E25-305DB948D208Q36402333-8EC1004F-C603-4D88-ABF2-09158BCB4545Q36741646-A5229CE7-2D05-45E9-9749-FA5A4DB0DD75Q37023688-5557BB87-21C9-480D-9F93-882EA233EE8DQ37279747-889426BF-2E4B-4E63-9D25-90322DE725F0Q37463275-169F3A36-55C9-49B4-A855-57F13828E4C0Q37619869-8228BFF0-3B7A-403C-BD3D-0C301ADBA393Q38046235-C15AA233-0FFC-4600-8267-375E29A52F71Q38476583-988CA040-5C09-402F-8520-CE0F95E57B71Q38742764-1208C861-FA56-4775-8652-A4EDAF363854Q38754089-3AB7DC42-FFE9-442E-930B-B382442AB3B5Q38972595-9A265EAB-FE37-475A-B18F-228C905A3597Q38983205-A74F63D9-8334-4EBB-89DE-0878512C8705Q38987271-3DD5D099-4B97-4A05-AC51-CF4F87640AD1Q39003086-E53AC3E0-42CD-4F62-8D7C-A2F448DC3ADDQ39076144-BA2C242A-3929-420C-AB0C-FAAF2BB88C81Q39112756-E2577011-C7AC-419C-8A02-206E65865B0FQ41900708-2CD003C3-B32F-4223-9D9F-C0BAAEED80F7Q43093685-4095328C-14B3-4E83-A580-62627E8A26E5Q45338889-CD916B87-EF9E-4DB3-933F-E9CC4AA5516EQ46035130-B99046AC-A17F-4B61-85CF-DA4DBCB8F590Q47360733-45EB69A9-7E7B-4DA2-A25E-DD4C19DB3CE3Q47379266-5DE72DD8-0672-4EFB-83D3-AB394CCE3778Q48214977-6AE48579-53A9-43C7-BBDB-D93C98B03F69Q49627330-724F4D73-ABEE-40D3-8C39-C71DC065AE65Q52741776-64A33286-3AB0-48CF-AC37-B6D962A8DB8DQ53089488-D6E7A0CF-7DEF-4781-B72E-45A6BF16381BQ53699332-B5E35C54-3911-44E2-926E-BB398EA9160CQ55435354-C43EAE4E-7AA2-42D6-A507-EAB2520B54A2
P2860
Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Androgen receptor and nutrient ...... g prostate cancer progression.
@en
Androgen receptor and nutrient ...... g prostate cancer progression.
@nl
type
label
Androgen receptor and nutrient ...... g prostate cancer progression.
@en
Androgen receptor and nutrient ...... g prostate cancer progression.
@nl
prefLabel
Androgen receptor and nutrient ...... g prostate cancer progression.
@en
Androgen receptor and nutrient ...... g prostate cancer progression.
@nl
P2093
P50
P1433
P1476
Androgen receptor and nutrient ...... ng prostate cancer progression
@en
P2093
Annora Thoeng
Colleen C Nelson
Cynthia Ng
Grant Buchanan
Jessamy Tiffen
John E J Rasko
Melanie L Lehman
Stephen C Hendy
Vineet Minhas
P304
P356
10.1158/0008-5472.CAN-11-1821
P407
P577
2011-10-17T00:00:00Z